Immune Effect of Co-Culture of Dendritic Cells and Cytokine-Induced Killer Cells on Prostate Cancer Cells
- PMID: 39448420
- DOI: 10.1007/s12013-024-01569-2
Immune Effect of Co-Culture of Dendritic Cells and Cytokine-Induced Killer Cells on Prostate Cancer Cells
Abstract
It was to explore the immune outcome of co-culture of dendritic cells (DC) and cytokine-induced killer cells (CIK) on prostate cancer (PCa) cells. Peripheral blood mononuclear cells (PBMCs) were extracted from healthy blood donors. DC and CIK cells were induced and co-cultured. The proliferation and phenotypic changes of DC, CIK, and DC-CIK cells/groups were observed. Model rats were constructed by injecting PC3 PCa cells into the abdominal cavity. The successful 50 cases were divided into a negative control group, a chemotherapy group, a DC group, a CIK group, and a DC-CIK treatment group (each consisting of 10 rats) to observe tumor progression. The secreted concentrations of interleukin-12 (IL-12) ((103.67 ± 2.77) pg/mL) and interferon-γ (IFN-γ) ((730.09 ± 23.52) pg/mL) were higher in DC-CIK group as against DC and CIK groups; the proliferation of CIK was higher in DC-CIK group as against CIK within 12 to 20 days of culture. The positive rate (PR) of CD3+/ CD56+ and CD8+ was higher and that of CD45RA+ was lower in DC-CIK group as against CIK.The killing rate of the DC-CIK group was higher than that of the DC and CIK groups at a target effect ratio of 10:1/20:1/50:1 (P < 0.05). After the treatment, the body weight of rats in the chemotherapy group, DC group, and CIK group was significantly reduced (P < 0.05), while no significant changes were observed in the negative control group and DC-CIK group (P > 0.05). After 25 days of treatment, the tumor size in the DC-CIK group was significantly smaller compared to the negative control group, chemotherapy group, DC group, and CIK group; the necrotic area of the tumor tissue in the DC-CIK group was also significantly larger than that in the negative control group, chemotherapy group, DC group, and CIK group (P < 0.05). Co-culture of DC and CIK is excellent in enhancing the proliferation of CIK cells, increasing the secretion of IL-12 and IFN-γ, and enhancing the activity of immune cells and anti-tumor ability, showing its potential in anti-PCa tumor immunotherapy.
Keywords: CIK; Co-culture; DC; Immune effect; PCa.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with Ethical Standards. Conflict of Interest: The authors declare no competing interests. Ethics Approval and Consent to Participate: All experimental protocols were approved by the Ethics Committee of the Tongxiang First People’s Hospital (Ethical No: TFPH320). All methods are reported in accordance with ARRIVE guidelines ( https://arriveguidelines.org ) for the reporting of animal experiments.
Similar articles
-
[Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):733-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396683 Chinese.
-
Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1150-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18928615
-
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.Chin J Cancer. 2010 Jul;29(7):641-8. doi: 10.5732/cjc.009.10772. Chin J Cancer. 2010. PMID: 20591215
-
Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.Cytotherapy. 2016 Sep;18(9):1162-77. doi: 10.1016/j.jcyt.2016.05.015. Epub 2016 Jul 12. Cytotherapy. 2016. PMID: 27421742
-
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis.Medicine (Baltimore). 2021 Apr 2;100(13):e24519. doi: 10.1097/MD.0000000000024519. Medicine (Baltimore). 2021. PMID: 33787569 Free PMC article.
References
-
- Zapała, P., Garbas, K., Lewandowski, Z., Ślusarczyk, A., Ślusarczyk, C., & Mielczarek, Ł., et al. (2023). Neutrophil-to-lymphocyte ratio predicts nodal involvement in unfavourable, clinically nonmetastatic prostate cancer patients and overall survival in pN1 patients. Scientific Reports, 13(1), 392 (1–8). - DOI - PubMed - PMC
-
- SopeñaSutil, R., Gómez Grande, A., González Díaz, A., Téigel Tobar, J., Cabeza Rodríguez, M. Á., & González Billalabeitia, E., et al. (2022). Role of F-Choline PET/CT in the initial staging of high risk prostate cancer and comparison with conventional imaging techniques. Archivos Espanoles de Urologia, 75(8), 684–692. - DOI
-
- Piramide, F., Bravi, C. A., Turri, F., DI Maida, F., Andras, I., & Lambert, E., et al. (2022). ERUS/YA U Working Group on Robot-assisted Surgery of the European Association of Urology. Retzius-sparing robot-assisted radical prostatectomy in high-risk prostate cancer: can it be as effective as the anterior approach in such a challenging setting? Cellular and Molecular Biology, 74(6), 807–809.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials